1. Home
  2. YQ vs CTXR Comparison

YQ vs CTXR Comparison

Compare YQ & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YQ
  • CTXR
  • Stock Information
  • Founded
  • YQ 2012
  • CTXR 2007
  • Country
  • YQ China
  • CTXR United States
  • Employees
  • YQ N/A
  • CTXR N/A
  • Industry
  • YQ Other Consumer Services
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • YQ Real Estate
  • CTXR Health Care
  • Exchange
  • YQ Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • YQ 19.4M
  • CTXR 23.0M
  • IPO Year
  • YQ 2020
  • CTXR N/A
  • Fundamental
  • Price
  • YQ $1.98
  • CTXR $1.37
  • Analyst Decision
  • YQ
  • CTXR Strong Buy
  • Analyst Count
  • YQ 0
  • CTXR 3
  • Target Price
  • YQ N/A
  • CTXR $53.00
  • AVG Volume (30 Days)
  • YQ 18.6K
  • CTXR 354.3K
  • Earning Date
  • YQ 08-27-2025
  • CTXR 08-12-2025
  • Dividend Yield
  • YQ N/A
  • CTXR N/A
  • EPS Growth
  • YQ N/A
  • CTXR N/A
  • EPS
  • YQ N/A
  • CTXR N/A
  • Revenue
  • YQ $25,546,613.00
  • CTXR N/A
  • Revenue This Year
  • YQ N/A
  • CTXR N/A
  • Revenue Next Year
  • YQ N/A
  • CTXR $851.67
  • P/E Ratio
  • YQ N/A
  • CTXR N/A
  • Revenue Growth
  • YQ N/A
  • CTXR N/A
  • 52 Week Low
  • YQ $1.26
  • CTXR $0.65
  • 52 Week High
  • YQ $3.19
  • CTXR $17.00
  • Technical
  • Relative Strength Index (RSI)
  • YQ 48.60
  • CTXR 48.63
  • Support Level
  • YQ $1.91
  • CTXR $1.23
  • Resistance Level
  • YQ $2.06
  • CTXR $1.43
  • Average True Range (ATR)
  • YQ 0.06
  • CTXR 0.10
  • MACD
  • YQ 0.01
  • CTXR 0.01
  • Stochastic Oscillator
  • YQ 73.08
  • CTXR 51.85

About YQ 17 Education & Technology Group Inc.

17 Education & Technology Group Inc is an education technology company in China. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: